安康性生活后阴道痒安康治疗妇科疾病妇科医院,安康外阴痒发白,安康带环后多久可以同房,安康女性下身痒怎么回事,安康得了盆腔积液能同房吗,安康nt多少钱,安康子宫切除后阴道干涩排不出来怎么办

The United States Supreme Court is expected to rule on several major cases next week impacting everything from abortion rights to the presidential election. Traditionally, the court issues all of it's rulings by the end of June to go on recess by early July. It's unclear this year however if the Supreme Court will extend its rulings if they are behind because of the pandemic. The Supreme Court said in advance what days justices will issue opinions, but would not announce which specific opinions will be announced on those days. Rulings typically come down around 10 a.m. ET.EXPECTED CASE #1 SEPARATION OF CHURCH AND STATE CHANGES?In Espinoza v. Montana Department of Revenue, the ruling could allow students in religious schools the ability to seek private scholarships funded through state income-tax credits. For years such programs were thought to be incompatible with Montana's constitutional ban on public aid to religious schools, however the Supreme Court could allow the program to exist. Because similar bans exist in 38 states, the ruling could change the definition of the separation of church and state. EXPECTED CASE #2CHANGE TO ABORTION RIGHTS?In June Medical Services LLC v. Russo, the ruling could impact the future of abortion rights across the country. The ruling examines whether a Louisiana law, which requires abortion providers to have admitting privileges in nearby hospitals, is constitutional. Abortion-rights activists say it will lead to clinics being shut down because most providers don't work with hospitals. More importantly, the ruling could tell anti-abortion leaders across the country that the High Court may be open to changes to Roe v Wade in the future. EXPECTED CASE #3ELECTORAL COLLEGE CONFUSION?In Colorado Department of State v. Baca, the ruling could result in major confusion in the 2020 election. The case is out of Colorado where in 2016, state electors to the electoral college attempted to vote for someone other than the winner of Colorado, Hillary Clinton. The electors were removed and replaced with someone to deliver the actual result, however it raised questions over how much power do these electors really have. EXPECTED CASE #4PRESIDENT TRUMP TAX RETURNS?In Trump v. Mazars USA, LLP and Trump v. Deutsche Bank, the question is whether the president has to comply with subpoenas for personal records. Does the power of the presidency allow President Donald Trump to say "no" when it comes to revealing his tax returns? If the Supreme Court rules against President Trump, it could create a new controversy for the President ahead of the election. 2615

The United States Coast Guard embodies the saying, "always ready."When forecasting natural disasters, however, those two words become much more than a motto -- they could mean the difference between life and death.“With natural disasters, they’re unpredictable," said USCG Capt. Will Watson, commander, Sector New Orleans. "There’s uncertainty but what you have to do is lean back on your training.” With U.S. Coast Guard stations across the country on standby, Watson said his teams are ready to help whenever and wherever they are needed.“When the time comes, and you face something that you maybe weren’t otherwise prepared for, that’s when you exercise on-scene initiative,” he said. “You think critically. You think creatively. Remain adaptable and flexible and act.”Southeast Louisiana locals are calling the U.S. Coast Guard, “heroes,” saying they saved more than lives during past natural disasters.“One day, I got stuck in a boat and they come over here, five of them come here, and helped me out,” said local fisherman Tony Buffone, who lost his house during Hurricane Katrina -- one of the most deadly and expensive natural disasters to hit U.S. soil.During recent storms, Buffone is now using lessons he learned from the U.S. Coast Guard.“It’s good to have good Coast Guard,” he said. “We got a good Coast Guard crew right there.”As the Gulf Coast deals with another massive hurricane, the U.S. Coast Guard is doing what it does best: staying “always ready”.“We have resources, assets, people from all across the Coast Guard ready to support this fight,” Watson said. “And we’re ready; ready to respond to Hurricane Laura.” 1643

The U.S. continues to lead the world in deaths linked to COVID-19 with more than 222,000 — and some experts believe that figure is much higher. But according to a new study, at least 130,000 of those deaths could have been avoided.According to a study by the National Center for Disaster Preparedness at Columbia University, the U.S. could have avoided between 130,000 and 210,000 COVID-19 deaths had the country adopted mitigation policies similar to those used by other "high-income nations."It's clear that the U.S. has disproportionately felt the affects of the pandemic — though it has just 4% of the world's population, it accounts for 20% of COVID-19 cases worldwide. The U.S. death toll stands in stark contrast to countries with similar resources, like South Korea, Japan, Australia, Germany, Canada, and France.To calculate the U.S.'s "avoidable deaths," the study applied the death rates of those countries to the U.S.'s population. Researchers then subtracted that figure from the U.S.'s current death count.By that calculation, researchers concluded that 130,000 lives could have been saved had the U.S. adopted policies similar to that of Canada's, and that as many as 215,000 lives could have been saved had the country adopted policies similar to South Korea.In explaining why U.S. deaths are disproportionately high, the Columbia researchers cited four key mistakes:Insufficient testing capacity: Researchers cited issues the U.S. had early on in the pandemic in developing and acquiring tests, while countries like South Korea were prepared almost immediately to test for the virus on a widespread scale.Delayed response: A previous Columbia University study determined that instituting national social distancing measures just one or two weeks earlier would have saved 36,000 of lives.Lack of a national mask mandate: Top health officials recommended against masks early on in the pandemic, fearing that doing so would lead to a shortage. Even today, masks have become politicized in some circles despite evidence showing that wearing one reduces the spread of droplets that can carry the virus.Failure from federal leadership: The Columbia study cited the Trump administration's "hostility to much of the critical guidance and recommendations put forth by its own health agencies," specifically citing the president's attempts to "downplay" the virus.Read more about the Columbia University study here. 2430

The suspect in the shooting deaths of two people at Central Michigan University is in custody, police reported early Saturday. Police spent most of Friday searching for a 19-year-old person of interest after two people were shot and killed on the campus of Central Michigan University on Friday. Scripps station WXYZ in Detroit is reporting that the victims are the suspect's parents.James Eric Davis Jr. is the suspect in the deaths of his parents James Davis Sr. and his wife, Diva Davis. Davis Sr. is a part-time police officer in Illinois in Chicago. Police later confirmed the identities of the victims.  652

The US Food and Drug Administration approved two cancer treatments, Vitrakvi and Xospata, this week after expedited reviews.Vitrakvi, approved Monday, is "a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker)."The FDA said in a statement that it is the second approved cancer treatment that is based on a tumor biomarker instead of the place in the body where the tumor originated.Vitrakvi will be used for the treatment of solid tumors that have an NTRK (neurotrophic receptor tyrosine kinase) gene fusion that do not have a known resistance mutation, that are not metastatic or where surgical removal is likely to lead to severe morbidity, and that have no alternative treatments or have progressed after treatments.NTRK genes are rare but occur in many types of cancer, the FDA said, such as mammary analogue secretory carcinoma and infantile fibrosarcoma.Xospata tablets, approved Wednesday, are for the "treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation," according to the FDA.Alongside the tablets, the agency also approved a diagnostic to detect the mutation."Approximately 25 to 30 percent of patients with AML have a mutation in the FLT3 gene. These mutations are associated with a particularly aggressive form of the disease and a higher risk of relapse," Dr. Richard Pazdur, director of the FDA's Oncology Center of Excellence, said in the statement.AML is a rapidly progressing cancer that affects the numbers of normal blood cells and calls for continuous transfusions, the FDA said.Both treatments were granted Priority Review designation.Priority Review, established in 1992, means the FDA aims to review the drug or treatment within six months, opposed to 10 months for a standard review."A Priority Review designation will direct overall attention and resources to the evaluation of applications for drugs that, if approved, would be significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications," the FDA says.Both treatments also received?orphan drug?designation, a status granted to drugs for rare diseases or conditions. 2261